Etilefrine

DB08985ApprovedWithdrawnSmall molecule

Etilefrine is an adrenergic agonist primarily of α1 and β1 receptors used as an anti-hypotensive. It has been used as a vasoconstrictor agent.

Mechanism: Pharmacologically active on Alpha-1D adrenergic receptor and Alpha adrenergic receptor
Curator reviewed
Formula / weight: C₁₀H₁₅NO₂ · 181.2316 g/mol (avg)
Code names: S 40032 · S 40032-7

Resolves to

Compound

Clinical / RWD

Structure

InChIKeySQVIAVUSQAWMKL-UHFFFAOYSA-NSMILESCCNCC(O)C1=CC=CC(O)=C1

Targets

Transporters

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

747Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

16ContraindicationsEach with its own population and attribute set

49Marketed productsAcross 5 countries and 17 labellers

2ATC codesIncluding every combination product, plus 23 drug categories

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Etilefrine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.